iSpecimen Inc. (Nasdaq:ISPC)
N/A • N/A
CIK 1558569
Company
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in July 2009 and is headquartered in Lexington, MA.
Address
450 Bedford Street
Lexington, Massachusetts 02420
450 Bedford Street
Lexington, Massachusetts 02420
Employees
75
75
Stock Info
Close
$0.4844
$0.4844
Day Range
0.4470 - 0.4900
0.4470 - 0.4900
52 Week Range
0.4000 - 2.0455
0.4000 - 2.0455
Average volume
45.75K
45.75K
Short Interest
20.31K (02/15/24)
20.31K (02/15/24)
% of Float Shorted
0.38%
0.38%
Market Cap
$4.25M
$4.25M
Revenue
$10.4M
$10.4M
Net Income
-$10.25M
-$10.25M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman Andrew L Ross |
Independent Director George Scholl |
Independent Director Theresa L Mock MBA |
Independent Director Steven R Gullans PhD |
Independent Director John L Brooks III, CPA |
SEC filings
Date | Form | Event |
---|---|---|
20 Dec, 2024 | 8-K | |
13 Dec, 2024 | 8-K | |
13 Dec, 2024 | 3 | |
12 Dec, 2024 | 8-K | |
12 Nov, 2024 | 8-K | |
7 Nov, 2024 | 10-Q | |
31 Oct, 2024 | 8-K | |
31 Oct, 2024 | 424B4 | |
29 Oct, 2024 | EFFECT | |
28 Oct, 2024 | CORRESP | |
28 Oct, 2024 | CORRESP | |
24 Oct, 2024 | UPLOAD | |
18 Oct, 2024 | S-1 | |
2 Oct, 2024 | 8-K | |
30 Sep, 2024 | 3 | |
30 Sep, 2024 | 4 | |
27 Sep, 2024 | 4 | |
27 Sep, 2024 | 4 | |
27 Sep, 2024 | 3 | |
27 Sep, 2024 | 3 | |
25 Sep, 2024 | 8-K | |
11 Sep, 2024 | 8-K | |
6 Aug, 2024 | 10-Q | |
6 Aug, 2024 | 8-K | |
22 Jul, 2024 | 8-K | |
9 Jul, 2024 | SCHEDULE 1 | |
8 Jul, 2024 | 8-K | |
3 Jul, 2024 | 8-K | |
10 Jun, 2024 | DEF 14A | |
10 Jun, 2024 | ARS | |
28 May, 2024 | PRER14A | |
20 May, 2024 | 4 | |
20 May, 2024 | 4 | |
20 May, 2024 | 4 | |
20 May, 2024 | 4 | |
20 May, 2024 | 4 | |
17 May, 2024 | 8-K | |
7 May, 2024 | 10-Q | |
7 May, 2024 | 8-K | |
11 Apr, 2024 | 8-K | |
28 Mar, 2024 | PRE 14A | |
26 Mar, 2024 | 8-K | |
26 Mar, 2024 | 3 | |
14 Mar, 2024 | 8-K | |
13 Mar, 2024 | 10-K | |
5 Mar, 2024 | 8-K | |
5 Mar, 2024 | 424B5 | |
15 Feb, 2024 | 8-K | |
13 Feb, 2024 | SC 13G/A | |
8 Feb, 2024 | 5 | |
21 Dec, 2023 | 8-K | |
2 Nov, 2023 | 10-Q | |
2 Nov, 2023 | 8-K | |
23 Oct, 2023 | 8-K | |
10 Oct, 2023 | 8-K | |
15 Sep, 2023 | 4 | |
6 Sep, 2023 | 8-K | |
2 Aug, 2023 | 8-K | |
2 Aug, 2023 | 10-Q | |
7 Jul, 2023 | 8-K | |
1 Jun, 2023 | 4 | |
25 May, 2023 | 8-K | |
17 May, 2023 | 4 | |
17 May, 2023 | 4 | |
17 May, 2023 | 4 | |
17 May, 2023 | 4 | |
17 May, 2023 | 4 | |
17 May, 2023 | 4 | |
4 May, 2023 | 10-Q | |
4 May, 2023 | 8-K | |
17 Apr, 2023 | SC 13D | |
10 Apr, 2023 | ARS | |
10 Apr, 2023 | DEF 14A | |
10 Apr, 2023 | DEFA14A | |
31 Mar, 2023 | 8-K | |
31 Mar, 2023 | PRE 14A | |
30 Mar, 2023 | 10-K/A | |
21 Mar, 2023 | 10-K | |
14 Mar, 2023 | 8-K | |
13 Feb, 2023 | SC 13G/A | |
10 Feb, 2023 | 5 | |
10 Feb, 2023 | 5 | |
10 Feb, 2023 | 5 | |
10 Feb, 2023 | 5 | |
10 Feb, 2023 | 5 | |
19 Jan, 2023 | 4 | |
19 Jan, 2023 | 4 | |
19 Jan, 2023 | 4 | |
13 Jan, 2023 | 4 | |
13 Jan, 2023 | 4 | |
13 Jan, 2023 | 4 | |
13 Jan, 2023 | 4 | |
13 Jan, 2023 | 4 | |
12 Jan, 2023 | SC 13G/A | |
10 Jan, 2023 | 8-K | CEO Change |
30 Dec, 2022 | 424B3 | |
27 Dec, 2022 | SC 13G/A | |
1 Dec, 2022 | 3 | |
28 Nov, 2022 | 8-K | |
14 Nov, 2022 | 4 | |
10 Nov, 2022 | 4 | |
8 Nov, 2022 | 8-K | |
8 Nov, 2022 | 10-Q | |
4 Nov, 2022 | 4 | |
4 Nov, 2022 | 4 | |
28 Oct, 2022 | 8-K | |
28 Sep, 2022 | SC 13G | |
22 Sep, 2022 | 8-K | CEO Change |
5 Aug, 2022 | EFFECT | |
5 Aug, 2022 | 424B3 | |
4 Aug, 2022 | 8-K | |
4 Aug, 2022 | 10-Q | |
3 Aug, 2022 | UPLOAD | |
3 Aug, 2022 | CORRESP | |
29 Jul, 2022 | S-3 | |
12 Jul, 2022 | EFFECT | |
8 Jul, 2022 | UPLOAD | |
8 Jul, 2022 | CORRESP | |
1 Jul, 2022 | S-3 | |
24 Jun, 2022 | 4 | |
24 Jun, 2022 | 4 | |
24 Jun, 2022 | 4 | |
24 Jun, 2022 | 4 | |
21 Jun, 2022 | 8-K | |
7 Jun, 2022 | 424B3 | |
6 Jun, 2022 | EFFECT | |
26 May, 2022 | 8-K | |
26 May, 2022 | POS AM | |
10 May, 2022 | 10-Q | |
10 May, 2022 | 8-K | |
29 Apr, 2022 | 8-K | |
14 Apr, 2022 | DEF 14A | |
14 Apr, 2022 | DEFA14A | |
30 Mar, 2022 | PRE 14A | |
22 Mar, 2022 | 10-K | |
7 Mar, 2022 | 8-K | |
24 Feb, 2022 | 4 | |
23 Feb, 2022 | 4 | |
17 Feb, 2022 | 8-K | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
14 Feb, 2022 | 5 | |
7 Feb, 2022 | SC 13G | |
24 Jan, 2022 | SC 13G | |
10 Jan, 2022 | 8-K | |
23 Dec, 2021 | 424B3 | |
23 Dec, 2021 | EFFECT | |
21 Dec, 2021 | UPLOAD | |
21 Dec, 2021 | CORRESP | |
16 Dec, 2021 | S-8 | |
14 Dec, 2021 | S-1 | |
9 Dec, 2021 | D | |
2 Dec, 2021 | 8-K | |
29 Nov, 2021 | 4 | |
29 Nov, 2021 | 8-K | |
17 Nov, 2021 | 4 | |
4 Nov, 2021 | 10-Q | |
4 Nov, 2021 | 8-K | |
16 Aug, 2021 | 8-K | |
10 Aug, 2021 | 8-K | |
10 Aug, 2021 | 10-Q | |
9 Jul, 2021 | SC 13G | |
1 Jul, 2021 | 8-K | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
22 Jun, 2021 | 8-K | |
18 Jun, 2021 | 424B4 | IPO completed |
17 Jun, 2021 | 3 | |
17 Jun, 2021 | 3 | |
17 Jun, 2021 | 3 | |
17 Jun, 2021 | 3 | |
17 Jun, 2021 | 3 | |
17 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | EFFECT | |
16 Jun, 2021 | CERT | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
14 Jun, 2021 | 8-A12B | |
14 Jun, 2021 | CORRESP | |
14 Jun, 2021 | CORRESP | |
28 May, 2021 | FWP | |
27 May, 2021 | S-1/A | |
13 May, 2021 | S-1/A | |
27 Apr, 2021 | CORRESP | |
27 Apr, 2021 | S-1/A | |
26 Apr, 2021 | UPLOAD | |
2 Apr, 2021 | CORRESP | |
2 Apr, 2021 | S-1/A | |
1 Feb, 2021 | UPLOAD | |
20 Jan, 2021 | S-1/A | |
20 Jan, 2021 | CORRESP | |
15 Jan, 2021 | UPLOAD | |
31 Dec, 2020 | CORRESP | |
14 Dec, 2020 | UPLOAD |
Last update:2024-03-06 13:28:58.064109
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.